Description
| Product Name | CAT.No | Size |
| Hbe Antigen | HBEAGC20 | 20T |
Product Description
The Biorex Diagnostics HBeAg One Step Rapid Test Device is a rapid immunochromatographic assay designed for the qualitative detection of Hepatitis B e Antigen (HBe antigen) in human serum or plasma. HBeAg is associated with high viral replication and increased infectivity in individuals with Hepatitis B Virus (HBV) infection, making its detection a critical marker in patient evaluation and clinical decision-making. The test provides fast and reliable screening to support assessment of active HBV replication, treatment planning, and risk of transmission.
Key Features
- Rapid detection – delivers clear qualitative results within minutes to support timely screening and clinical assessment
- High sensitivity and specificity – accurate identification of HBe antigen for reliable evaluation of infectivity and viral replication status
- Versatile sample compatibility – works with serum or plasma, integrating seamlessly into standard laboratory workflows
- Instrument-free operation – ideal for point-of-care testing in clinics, hospitals, mobile health units, and resource-limited environments
- User-friendly format – minimal preparation required with straightforward interpretation and small sample volume
Benefits
Routine use of the HBeAg One Step Rapid Test Device supports early and efficient identification of individuals with high viral loads and active HBV replication. Detection of HBe antigen enables healthcare providers to assess disease progression, evaluate treatment strategies, and determine infectivity levels, which is particularly important for maternal–fetal transmission risk, household exposure monitoring, and patient counseling. The test’s rapid turnaround time enhances clinical workflows by minimising delays in decision-making, while its instrument-free design allows flexible deployment in both routine laboratory settings and decentralised healthcare environments.
Beyond individual patient care, the assay provides value for public health screening, epidemiological surveillance, and HBV control initiatives. By enabling quick stratification of infection status, it contributes to improved transmission prevention efforts and supports long-term monitoring programmes. Its robust analytical performance, ease of use, and reliable operation make the HBeAg Rapid Test a dependable tool for clinicians, laboratories, and healthcare systems seeking timely information on HBV infectivity and disease management. Overall, the Biorex Diagnostics HBeAg One Step Rapid Test Device delivers fast, accurate, and clinically relevant results essential for modern Hepatitis B evaluation.
Contact Us for more information.